Table 5.
HIV specific symptoms | FACE intervention n = 20 |
HLC comparison n = 18 |
P value |
---|---|---|---|
Physical/bodily pain | 5% | 0% | 0.210 |
Coughing/Wheezing | 10% | 0% | 0.604 |
Nausea/vomiting | 5% | 0% | 0.737 |
Skin problems (rash, itching, etc) | 5% | 0% | 0.063+ |
Fatigue | 0% | 5% | 0.095+ |
Feeling dizzy/lightheaded | 5% | 0% | 0.178 |
Fever/night sweats/shaking/chills | 5% | 0% | 0.737 |
Loss of appetite | 5% | 0% | 0.663 |
Trouble sleeping | 0% | 0% | 0.058+ |
Eye trouble/problems with vision | 0% | 5% | 0.734 |
Headaches | 5% | 0% | 0.342 |
Dry or painful mouth/trouble swallowing | 0% | 0% | 1.0 |
Chest pain or tightness | 5% | 0% | 1.0 |
Difficulty breathing or catching breath | 0% | 0% | 0.656 |
Runny nose/sinus trouble | 10% | 0% | 0.479 |
Muscle aches/joint or bone pain | 0% | 0% | 0.232 |
Pain, numbness or tingling | 0% | 0% | 0.792 |
Overall discomfort | 0% | 0% | 0.697 |
Notes: All P values control for baseline using a t-test to assess significance at the 0.05 level.
Abbreviations: FACE, Family Centered Advance Care planning; EOL, end-of-life; HIV/AIDS, human immunodeficiency virus/acquired immune deficiency syndrome; HLC, healthy living control.